Irritable bowel syndrome (IBS) is the most common gastrointestinal disorder, affecting 10-15% of the world’s population. Approximately two-thirds of those who suffer from IBS are women. The disease can have mild forms or cause severe debilitation as diarrhea alternates with constipation. Severe cramping and bloating also are common. Because chronic IBS is so debilitating, it often disrupts the daily lives of people with this disorder.

April is IBS Awareness Month, so we recently spoke with Mark Pimentel, MD, about the primary cause of IBD, a definitive test for the disease and ways to manage the chronic illness. Dr. Pimentel is an associate professor of gastroenterology and executive director of the Medically Associate Science and Technology program at Cedars-Sinai. He led the research initiative to develop the first ever diagnostic blood test for IBS.

Connect with us:

[ Ссылка ]
[ Ссылка ]
[ Ссылка ]

Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.

свернуть